{
  "schemaVersion": 1,
  "id": "veranta",
  "version": "1.1.0",
  "name": "Veranta (formerly Avantis)",
  "reviewedAt": "2026-10-22",
  "reviewIntervalDays": 14,
  "reviewer": "Decentralised News editorial research",
  "evidenceType": "provider_documentation",
  "liveTested": false,
  "summary": "Veranta documents USDC margin on Base and session-based trading permissions. Its fee pages disagree on maker rates and Upside borrowing costs. Treat zero-commission claims as product-specific; no definitive total-cost comparison or live security assessment is established.",
  "scope": "Review of all six brief claims against nine current official sources retrieved through web search and page retrieval. Original overview and blog references are replaced by specific product pages. No live trading, wallet-signing, revocation, payout or eligibility test; the profit-sharing tier graphic was not verified.",
  "sources": [
    {
      "id": "identity",
      "name": "Official developer organisation: formerly Avantis",
      "url": "https://github.com/Avantis-Labs",
      "reviewedAt": "2026-10-22"
    },
    {
      "id": "collateral",
      "name": "Collateral and position sizing",
      "url": "https://docs.veranta.xyz/trading/getting-started/collateral-and-position-sizing",
      "reviewedAt": "2026-10-22"
    },
    {
      "id": "fees",
      "name": "Fee schedule by asset class",
      "url": "https://docs.veranta.xyz/trading/fees/fee-schedule-by-asset-class",
      "reviewedAt": "2026-10-22"
    },
    {
      "id": "maker-taker",
      "name": "Maker and taker",
      "url": "https://docs.veranta.xyz/trading/fees/maker-and-taker",
      "reviewedAt": "2026-10-22"
    },
    {
      "id": "upside-mechanics",
      "name": "Upside mechanics",
      "url": "https://docs.veranta.xyz/trading/upside-perps/mechanics",
      "reviewedAt": "2026-10-22"
    },
    {
      "id": "profit-sharing",
      "name": "Upside profit sharing",
      "url": "https://docs.veranta.xyz/trading/upside-perps/profit-sharing",
      "reviewedAt": "2026-10-22"
    },
    {
      "id": "permissions",
      "name": "Gasless and one-click trading",
      "url": "https://docs.veranta.xyz/trading/getting-started/gasless-trading-and-one-click-trading.",
      "reviewedAt": "2026-10-22"
    },
    {
      "id": "execution",
      "name": "Execution and pricing",
      "url": "https://docs.veranta.xyz/trading/execution-and-pricing",
      "reviewedAt": "2026-10-22"
    },
    {
      "id": "terms",
      "name": "Terms of Service, revised September 2026",
      "url": "https://www.veranta.xyz/docs/tos",
      "reviewedAt": "2026-10-22"
    }
  ],
  "networks": [
    {
      "id": "base",
      "name": "Base",
      "collaterals": [
        "USDC"
      ],
      "sourceId": "collateral"
    }
  ],
  "claims": [
    {
      "id": "identity",
      "question": "Is this still Avantis?",
      "label": "Provider-reported",
      "finding": "The official developer organisation identifies Veranta as formerly Avantis and links to the Veranta website and documentation. This review does not date the rebrand or establish equivalence between old and current product instructions.",
      "consequence": "Use the current name and documentation; do not assume older instructions still describe the product.",
      "sourceIds": [
        "identity"
      ]
    },
    {
      "id": "collateral",
      "question": "Which network and margin asset are described?",
      "label": "Provider-reported",
      "finding": "The collateral page describes USDC margin and isolated positions. The terms identify Base as the protocol network. These are provider statements, not tests of deployed collateral or loss boundaries.",
      "consequence": "Confirm the selected network, token and deposit route before moving assets. This does not establish every supported funding method.",
      "sourceIds": [
        "collateral",
        "terms"
      ]
    },
    {
      "id": "fees",
      "question": "Does zero commission mean zero total cost?",
      "label": "Documentation conflict",
      "finding": "The fee schedule prose assigns 4.5 bps to takers and 1 bp to makers; its table reverses the labels. The maker/taker page instead lists 0.001% (0.1 bp) for makers. The schedule includes borrowing for Upside, while Upside mechanics says no borrowing and describes trader-to-trader funding. RWA commission is described as zero during growth mode, with spread and holding costs. Profit-sharing text describes retaining 75–95%, depending on ROI; the tier graphic and live payout calculation were not verified.",
      "consequence": "Do not use these conflicting figures as a definitive fee quote. Check the exact product and order breakdown, including funding, spread and profit share. DN has not established a cheapest venue or a complete numerical schedule.",
      "sourceIds": [
        "fees",
        "maker-taker",
        "upside-mechanics",
        "profit-sharing"
      ]
    },
    {
      "id": "execution",
      "question": "Has DN verified execution quality?",
      "label": "Not measured",
      "finding": "The current page describes oracle-based pricing, spreads and RWA request-for-quote execution. It also retains unfilled confirmation placeholders for Korean-equity spread and price-check arrangements. Provider examples are not independent DN fill or latency measurements.",
      "consequence": "No measured fill-quality, latency, withdrawal or stop-loss ranking is supported here.",
      "sourceIds": [
        "execution"
      ]
    },
    {
      "id": "permissions",
      "question": "What authority does one-click trading require?",
      "label": "Provider-reported",
      "finding": "The detailed page describes session signers with user-selected expiry and revocation. EVM-wallet gas sponsorship requires Smart Wallet mode; ordinary transactions without that mode pay gas. DN did not inspect live signing requests or test expiry and revocation.",
      "consequence": "Read the exact session authority and wallet mode before signing, and verify revocation independently. Documented controls do not establish deployed safety.",
      "sourceIds": [
        "permissions"
      ]
    },
    {
      "id": "access",
      "question": "Does wallet access establish eligibility?",
      "label": "Provider-reported",
      "finding": "The reviewed terms exclude defined U.S. persons and restricted persons and require users to meet age and other conditions.",
      "consequence": "Read the complete current terms. Absence from these examples is not confirmation of eligibility or local legal compliance.",
      "sourceIds": [
        "terms"
      ]
    }
  ],
  "illustration": null,
  "unknowns": [
    "Definitive maker/taker rate mapping and current pair-specific costs",
    "Consistent Upside borrowing treatment and verified profit-sharing tier calculation",
    "Live permission scope, expiry enforcement and revocation behaviour",
    "Korean-equity execution details left as confirmation placeholders by the provider",
    "Live execution, stop-loss and withdrawal performance",
    "Individual legal access and suitability"
  ],
  "accessGaps": [],
  "history": [
    {
      "date": "2026-10-22",
      "type": "DN evidence revision",
      "detail": "Re-reviewed all six claims with nine official sources. Incorporated the previously accessed detail pages, recorded the additional maker-rate unit discrepancy and execution-page placeholders, and retained live-test limitations. Historical 1.0.0 and its 15 October follow-up remain unchanged."
    },
    {
      "date": "2026-10-14",
      "type": "DN publication",
      "detail": "Initial Veranta brief with Avantis alias. Verified the identity using provider sources; recorded detail-page access gaps. This is the DN review date, not the rebrand announcement date."
    }
  ],
  "reviewTriggers": [
    "A reconciled fee schedule or corrected execution documentation",
    "Changed collateral, session-permission or access terms",
    "A substantiated correction",
    "The 14-day review deadline"
  ],
  "disclosure": "DN has an existing Avantis referral entry. Its applicability after the rebrand has not been verified in this brief. No new referral destination or active partner CTA is supplied. Compensation has no role in the evidence labels."
}
